AbbVie and BioLabs announce winners of Japan Innovation Award

AbbVie Japan, in collaboration with BioLabs, has announced the winners of the ‘AbbVie Japan Innovation Award’. The initiative aims to support promising Japanese biotechnology companies and academic institutions to foster the local innovation ecosystem and translate research into medical solutions.

Tuning Fork Bio, Inc. received the ‘Golden Ticket Program’ award. The company utilizes protein microarray technology from Fukushima Medical University combined with AI analysis to identify new drug targets and therapeutic antibodies for cancer and immune diseases. As part of the award, they will receive one year of free access to the BioLabs Tokyo incubation facility and mentoring from AbbVie R&D experts.

Neoclease, Inc. was awarded the ‘AbbVie Special Mentoring Program’. The company has developed an AI platform to design novel gene-editing technologies optimized for specific diseases, aiming to accelerate gene therapies for hereditary conditions such as Parkinson’s disease. They will receive specialized mentoring from AbbVie’s research and development professionals.